None
Conditions
Interventions
A group:novel non-pharmacological, passive electrical signal analgesic device
B group:oral or intravenous non-steroidal anti-inflammatory drugsdevice
Sponsors
Peking Union Medical College, Chinese Academy of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 45 Years
Inclusion criteria
Inclusion criteria: 1 .Patients undergoing cesarean section at term with singleton pregnancy; 2.Age between 18 and 45 years; 3. American Society of Anesthesiologists (ASA) physical status classification I–II; 4.No history of alcohol or anesthetic drug addiction; 5.No prenatal depression or other psychiatric disorders, and able to cooperate with all study procedures; 6.Good compliance, available for postpartum follow-up; 7.Complete clinical records and provision of informed consent.
Exclusion criteria
Exclusion criteria: 1.Patients with major organ dysfunction, such as severe cardiovascular, cerebrovascular, hepatic, or renal diseases; 2. Patients with pregnancy complicated by autoimmune diseases, preeclampsia, or gestational diabetes; 3. Patients who have taken opioid analgesics or anti-inflammatory drugs within 2 days prior to surgery; 4.Patients with a history of chronic pain; 5. Patients contraindicated for neuraxial anesthesia;6. Patients allergic to the study medication (Voltaren).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sum of Pain Intensity Difference over 48 hours; | — |
Secondary
| Measure | Time frame |
|---|---|
| Safety (incidence of adverse reactions and complications);Scar severity ;Inflammatory cytokine levels ;Wound healing quality ; | — |
Countries
China
Contacts
Public ContactZhou Qian
Peking Union Medical College, Chinese Academy of Medical Sciences
Outcome results
None listed